“Kisspeptin 2017: Brain & Beyond” is now accepting abstracts.

Abstracts submitted to ENDO 2017 can also be submitted to “Kisspeptin 2017: Brain & Beyond” and will be considered for poster presentation. Note: while both meetings will accept the same abstract, these must be submitted separately and will be reviewed independently of each other. To facilitate dual submissions, both ENDO 2017 and Kisspeptin 2017: Brain & Beyond follow a similar abstract format where abstracts are limited to text and only to a maximum of 2,500 characters, excluding spaces (for more details see “Submission Instructions” below).

The Program Committee welcomes abstracts reporting unpublished basic, clinical or translational research findings concerning kisspeptin and related peptides in the brain and body. Please adhere to all rules for the submission and format of abstracts. Before submitting an abstract, the presenting author must first register to attend “Kisspeptin 2017: Brain & Beyond”. There is no charge for submitting an abstract to this meeting.

Registration to attend “Kisspeptin 2017: Brain & Beyond” is handled by the Endocrine Society. The following link will redirect you to the registration page. Endocrine Society registration site

After you have registered, return to this page and submit your abstract.

Submission Instructions

  1. Prepare your abstract in Microsoft Word or Rich Text Format (RTF) on a page formatted with 0.75 inch (1.9 cm) margins all around. Use a 10-point Arial font. The body of the abstract (excluding title, authors, and affiliations) must not exceed 2,500 characters (not including spaces). Graphics and images are not allowed. The presenting author’s name must be listed first and underlined in the list of authors. For an example of a properly formatted abstract, please view here.
  2. Submit your abstract as an email attachment to abstract@kisspeptin2017.org by February 15, 2017 with the presenting author’s full name in the subject field.
  3. You will immediately receive an email confirmation of your submission.
  4. The Program Committee will review all abstracts and you will be notified in a timely manner whether your abstract has been accepted for a poster presentation.